For biologic cell lysis
(bacteria, yeast, algae and plants) cells can be efficiently disrupted with a
pressure shock in order to collect the intracellular materials, drastically
reducing the production time and costs.
In this respect Niro Soavi VHP Homogenizer offers distinct advantages over chemical lysis
and impinging flow type technologies. Whereas chemical lysis require additional
costly purification and recovery process steps to yield the desired product,
the Niro Soavi VHP require no additional processing steps, achieving yields
higher than 90% on a single pass with industrial size cells disruption units.
Unlike impinging flow type equipment, Niro Soavi VHP Homogenizer can
be easily scaled-up from the lab and pilot systems to industrial systems,
consistently replicating the process results.
Particle size reductions
for the
pharmaceutical industry
can usually be accomplished at lower pressures than competing technology with
appropriate selection of the most suitable
homogenizing valve sizing, design and FDA grade
wear resistant materials.